Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer.
Yang J, Yan J, Shao J, Xu Q, Meng F, Chen F, Ding N, Du S, Zhou S, Cai J, Wang Q, Liu B.
Yang J, et al. Among authors: xu q.
Onco Targets Ther. 2019 Nov 15;12:9757-9765. doi: 10.2147/OTT.S233496. eCollection 2019.
Onco Targets Ther. 2019.
PMID: 31814734
Free PMC article.